Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.855 USD | +2.64% | +17.72% | +96.36% |
05-16 | Ventyx Biosciences Appoints Matthew Moore as Chief Operating Officer; Shares Rise | MT |
05-16 | Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+96.36% | 333M | |
+9.72% | 115B | |
+11.68% | 106B | |
-2.59% | 21.96B | |
-13.31% | 21.87B | |
-5.29% | 19.21B | |
-4.27% | 18.08B | |
-38.57% | 17.71B | |
+6.50% | 14.32B | |
+33.98% | 12.42B |
- Stock Market
- Equities
- VTYX Stock
- News Ventyx Biosciences, Inc.
- Transcript : Ventyx Biosciences, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 10